Effect of a Higher Blood-pressure on Right Ventricular Function
1 other identifier
interventional
78
1 country
1
Brief Summary
Right ventricular (RV) dysfunction in cardiac surgery is an independent risk factor for morbidity and mortality. Raising the systemic blood pressure with norepinephrine seems to have a positive influence on the right ventricular function in several animal studies. The current study is designed to evaluate the effect of a higher blood pressure on the RV function in post cardiac surgery patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2018
CompletedFirst Posted
Study publicly available on registry
January 16, 2019
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2020
CompletedMay 27, 2020
May 1, 2020
1.2 years
October 29, 2018
May 25, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
right ventricular ejection fraction
Primary endpoint is the difference between the intervention and the control group in the change over time between baseline and the end of the study period (T4) in RVEF.
2 hours postoperative
Secondary Outcomes (4)
Echocardiographic
2 hours postoperative
RV end-diastolic pressure
baseline and 15 minutes postoperatively
Cardiac index
2 hours postoperative
Fluid balance
2 hours postoperative
Study Arms (2)
intervention
ACTIVE COMPARATORintervention with norepinephrine to reach a MAP of 85 mmHg for a maximum duration of 1 hour, observation of the effect on right ventricular function
control
NO INTERVENTIONcontrol group; treatment according to current standards, observation of the effect on right ventricular function
Interventions
Eligibility Criteria
You may qualify if:
- post operative cardiac surgery patients, full sternotomy
- admission at ICU
- informed consent
- right ventricular monitoring by pulmonary artery catheter.
- RVEF \<30% + MAP ≤ 65mmHg
You may not qualify if:
- no informed consent
- acute surgery
- Off pump cardiac surgery
- Severe tricuspid insufficiency
- Allergy to norepinephrine
- Severe left ventricular hypertrophy with systolic anterior movement
- Chronic use of alpha-blockers
- Irregulair heart rhythm
- Surgical reasons to maintain a low blood pressure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical Center Leeuwarden
Leeuwarden, 8904 BR, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christiaan Boerma, Dr
Frisius Medisch Centrum
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- open label study
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
October 29, 2018
First Posted
January 16, 2019
Study Start
March 1, 2019
Primary Completion
May 15, 2020
Study Completion
May 25, 2020
Last Updated
May 27, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share